Biology moves faster than the infrastructure designed to carry it. The principals who own that gap meet at BILS.
01
Every biologics leader is asked the same question. How does discovery become medicine at scale. The platform between candidate and patient is being rebuilt.
02
The white space is the room that holds the conversation differently. Closed-door. By invitation. End-user led. No expo hall. No vendor pitch. A circle for the leaders building what comes next.
03
the Conversation. BILS is that room. Senior biologics leadership convened around the work that compounds. Upstream. Downstream. CDMO. Digital manufacturing and supply. Less noise. More signal.
04
Who attends. Senior faculty drawn from the leaders who own the plant, sign the batch and carry the accountability. Announced in cadence with the programme.
The role that does not yet exist at scale.
The gap.
Biology moves faster than infrastructure. Leaders know they must scale · few yet have the process. Facilities without governance · stall. Pilots without scale · break. The line between drug candidate and clinical supply is the decision that holds both.
the Circle.
BILS convenes the leaders preparing for that role · across drug discovery, R&D, manufacturing and supply. The corridor where AI ambition becomes clinical outcome · or breaks. the Circle closes the gap.
The decision.
What scales. What purifies. Who manufactures the future. Three questions the room must hold before the queue forms. For the leaders shaping what comes next.
By invitation. By relevance. By room.
Attend BILS 2027